Agonists of immune checkpoint modulators for treating autoimmune and inflammatory disorders have shown high potential in ...

Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the tumor site, enabling them to target ...